Business
PNDX_B: Dalata acquisition and robust Q4 growth drive higher earnings and positive 2026 outlook
PNDX_B: Dalata acquisition and robust Q4 growth drive higher earnings and positive 2026 outlook
About this update from Pandox Ab Class B
Q4 2025 saw strong like-for-like growth, boosted by the Dalata acquisition, which increased revenues, NOI, and international exposure. Financial metrics improved, with a 23% rise in cash earnings and a 7.7% EPRA NRV increase. 2026 outlook is positive, especially for the Nordics and Germany.Based on This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.